J&J Partnership, page-306

Little reminder gents (and ladies) of the trial:

https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=372643

Secondary outcomes are function and pain measurements including VAS scores. Lets not forget on a 0-10 pain score, ATI saw improvements from 5.94 at the initial assessment to 0.76 at 12 months (P < .001) in its lateral epicondylitis study. The best measure of the success was for me grip strength scores improving over the 12-month follow-up from 20.17 kg [baseline] to 37.38 kg; P < .001):

https://journals.sagepub.com/doi/abs/10.1177/0363546513504285

Pretty compelling stuff for those who've ever endured tendinosis. I am very excited by these forthcoming results and only wish they'd including more secondary data - but too many studies get loaded down with multiplicity criticisms, so OCC have kept it simple with preferred orthcopedic composite measures.